# Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

> **NCT01952392** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4992 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01952392
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 4992 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01952392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01952392, "Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01952392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*